Overview / Abstract: |
Dive into this engaging, digital newsletter created by our multidisciplinary faculty panel, Christoph Correll, MD and Rose Mary Xavier, PhD, MS, RN, PMHNP-BC to learn proper recognition and management of tardive dyskinesia (TD). This newsletter includes guidance on diagnostic criteria, treatment algorithms, as well as strategies with how to incorporate novel therapies while ensuring optimal adherence and patient quality of life. |
Expiration |
Nov 09, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Psychology CE |
Credits / Hours |
.75 |
Accreditation |
ACCME, AANN |
Presenters / Authors / Faculty |
Christoph U. Correll, MD (Chair) Rose Mary Xavier, PhD, MS, RN, PMHNP-BC (Nurse Planner) |
Activity Specialities / Related Topics |
Neurology, Psychiatry / Mental Health |
Sponsors / Supporters / Grant Providers |
Supported by an educational grant from Teva Pharmaceuticals. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, Continuing Education, Enduring CME, Enduring CE, Enduring Newsletter, eNewsletter, AANN, American Academy of Neurology Nurses, freeCME, ACHL, Academy for Continuing Healthcare Learning, Virtual CME, Virtual CE, Teva, tardive dyskinesia, TD, neurology, psychiatry, neuropsychiatry, mental disorders, schizophrenia, hyperkinetic, movement disorder, psychotropic, dopamine agonist,antipsychotic Free CE CME |